Talent, passion and commitment. If that describes you, we welcome you to work for a company that makes a difference.
At bioAffinity Technologies, the work we do helps patients prevail over cancer and other serious diseases. Our first product, CyPath® Lung, addresses the urgent need for noninvasive detection of early-stage lung cancer. Research and development is focused on tests for other diseases of the lung and broad-spectrum cancer treatments.
Our Company Mission:
bioAffinity Technologies applies experience, intelligence and creativity to the global fight against cancer. We know that by unlocking our personal potential, we make discoveries that give others an opportunity to live longer and more enjoyable lives. Our commitment is to continual scientific exploration, transparency and collaboration, and the development and commercialization of patient-friendly tests that accurately diagnose early-stage cancer and provide safer, more effective cancer treatments.